Association of the End-Stage Renal Disease Treatment Choices Payment Model With Home Dialysis Use at Kidney Failure Onset From 2016 to 2022

Authors:

Abstract
Dialysis performed at home can offer a sense of control, independence, self-efficacy, and flexibility, factors that are important to many patients who require maintenance dialysis.1,2 Use of home dialysis has been increasing over the past decade. Nevertheless, only 13% of patients undergoing dialysis in the US do so at home.3 The Advancing American Kidney Health Executive Order, signed by the US president in 2019, set forth ambitious targets for increased use of home dialysis in the US. Subsequently, the Centers for Medicare & Medicaid Services (CMS) introduced payment models to incentivize home dialysis, including the End-Stage Renal Disease Treatment Choices (ETC) model, in which outpatient dialysis facilities and health care professionals providing nephrology services were randomly assigned to mandatory participation at the hospital referral region (HRR) level.4 The HRRs assigned to ETC were announced in September 2020, and ETC was launched in January 2021. For the first 2 years, clinicians and organizations (hereafter, providers) assigned to ETC received financial incentives to transition patients with chronic kidney disease stage 4 or 5 to home dialysis rather than in-center hemodialysis (Home Dialysis Payment Adjustment).5,6 Beginning in July 2022, these providers are subject to a performance pay adjustment that rewards higher rates of home dialysis use, waitlisting for kidney transplant, and preemptive kidney transplant, and penalizes lower rates using national quartiles as benchmarks.

This publication has 5 references indexed in Scilit: